A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Novavax on Wednesday said the Food and Drug Administration has put a hold on its application for a combination […]
Blue Origin CEO Dave Limp, left, and founder Jeff Bezos look up at a New Glenn rocket on at the company’s LC-36 facility in Florida. Blue Origin Dave Limp had only one question for Jeff Bezos when he interviewed last year to become CEO of Blue Origin, the billionaire’s space venture. “Jeff, is Blue Origin
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly will spend $4.5 billion to build a center aimed at finding better ways to manufacture its medicines. The facility, called the Lilly Medicine Foundry, will house development of
An Impulse employee works on assembling a Mira vehicle. Impulse Space Los Angeles-based space startup Impulse, which is led by renowned rocket specialist Tom Mueller, has raised $150 million in a new fundraising round led by venture capital firm Founders Fund. Impulse is scaling a product line of orbital transfer vehicles — colloquially known as
Bristol Myers Squibb’s Cobenfy drug Courtesy: Bristol Myers Squibb The Food and Drug Administration on Thursday approved Bristol Myers Squibb‘s highly anticipated schizophrenia drug Cobenfy, the first novel type of treatment for the debilitating, chronic mental disorder in more than seven decades. Schizophrenia affects how a person thinks, feels and behaves, and can cause paranoia,
A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters Novo Nordisk‘s blockbuster diabetes drug Ozempic may decrease the risk of opioid overdoses in certain patients, demonstrating its potential as an alternative treatment for opioid use disorder, according to a new study
Novo Nordisk’s diabetes drug Ozempic may lower the risk of opioid overdoses, study says Read More »
The company’s IM-1 mission lander shortly after launching on Feb. 15, 2024. Intuitive Machines Intuitive Machines‘ stock jumped in early trading Wednesday after NASA awarded the lunar-focused company a major contract to build moon data satellites. “This contract marks an inflection point in Intuitive Machines’ leadership in space communications and navigation,” Intuitive Machines CEO Steve
Pfizer‘s experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive results in a midstage trial, the drugmaker said Saturday. Patients with the condition, called cancer cachexia, who took Pfizer’s treatment saw improvements in body weight, muscle mass, quality of life and physical function, according to
Thomas d’Halluin, managing partner of Airbus Ventures, at Hangar One of NASA Ames Research Center’s Moffett Field in California. Airbus Ventures Airbus Ventures, one of the most prolific investors in space startups, has raised a $155 million fund that it plans to deploy across the burgeoning space sector, as well as the broader “deep tech”
Airbus Ventures launches $155 million fund focused on deep tech, including space Read More »
Polaris Dawn commander Jared Isaacman emerges from SpaceX’s Dragon capsule during a spacewalk on Sept. 12, 2024. SpaceX SpaceX pulled off its first spacewalk in the early hours of Thursday morning, in a historic first for a company. The marquee event of the private Polaris Dawn mission went smoothly, with two of the crew members
SpaceX performs historic first spacewalk with Polaris Dawn crew Read More »
